AppRecs review analysis
AppRecs rating 4.1. Trustworthiness 69 out of 100. Review manipulation risk 15 out of 100. Based on a review sample analyzed.
★★★★☆
4.1
AppRecs Rating
Ratings breakdown
5 star
86%
4 star
0%
3 star
0%
2 star
0%
1 star
14%
What to know
✓
Low review manipulation risk
15% review manipulation risk
✓
High user satisfaction
86% of sampled ratings are 4+ stars (4.4★ average)
About Caris+
The Caris+ App provides convenient access to manage and review Caris profiling cases. View current and past patient results whenever and wherever you are.
• View and search current and past cases
• Receive real-time case notifications
• Track testing progress
• Approve orders
• View interactive results and select clinical trial matches
• Request Caris Molecular Tumor Board review
• Share patient educational information
About Caris Life Sciences
Caris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions.
Caris is also advancing precision medicine with Caris Artificial Intelligence, combining its market leading service offering, Caris Molecular Intelligence® with its proprietary artificial intelligence analytics engine, DEAN™. This information, coupled with mature clinical outcomes on thousands of patients, provides unmatched molecular solutions for patients, physicians, payers and biopharmaceutical organizations.
• View and search current and past cases
• Receive real-time case notifications
• Track testing progress
• Approve orders
• View interactive results and select clinical trial matches
• Request Caris Molecular Tumor Board review
• Share patient educational information
About Caris Life Sciences
Caris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions.
Caris is also advancing precision medicine with Caris Artificial Intelligence, combining its market leading service offering, Caris Molecular Intelligence® with its proprietary artificial intelligence analytics engine, DEAN™. This information, coupled with mature clinical outcomes on thousands of patients, provides unmatched molecular solutions for patients, physicians, payers and biopharmaceutical organizations.
